Compounds > raloxifene hydrochloride
Page last updated: 2024-08-23

raloxifene hydrochloride and Adenoma, Basal Cell

raloxifene hydrochloride has been researched along with Adenoma, Basal Cell in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brewer, M; Bryant, T; Janakiram, NB; Lightfoot, S; Mohammed, A; Rao, CV; Steele, VE; Zhang, Y1
Reincke, M1
Barone, G; Bollati, A; Bonfanti, C; Burattin, A; Cozzi, R; Giustina, A; Poiesi, C; Tulipano, G; Turazzi, S; Valle, D1
Gabriel, SM; Koenig, JI; Washton, DL1

Other Studies

4 other study(ies) available for raloxifene hydrochloride and Adenoma, Basal Cell

ArticleYear
Chemopreventive efficacy of raloxifene, bexarotene, and their combination on the progression of chemically induced colon adenomas to adenocarcinomas in rats.
    Cancer prevention research (Philadelphia, Pa.), 2013, Volume: 6, Issue:12

    Topics: Adenocarcinoma; Adenoma; Adult; Aged; Animals; Anticarcinogenic Agents; Apoptosis; Azoxymethane; Bexarotene; Biomarkers, Tumor; Blotting, Western; Colonic Neoplasms; Drug Therapy, Combination; Estrogen Antagonists; Estrogen Receptor beta; Female; Humans; Immunoenzyme Techniques; Male; Middle Aged; Neoplasm Grading; Raloxifene Hydrochloride; Rats; Rats, Inbred F344; Real-Time Polymerase Chain Reaction; Retinoid X Receptors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrahydronaphthalenes; Tissue Array Analysis; Tumor Cells, Cultured

2013
[Diabetes, Conn syndrome and osteoporosis. What is new in diagnosis and therapy?].
    MMW Fortschritte der Medizin, 2003, Feb-27, Volume: 145, Issue:9

    Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aged; Coronary Disease; Diabetes Mellitus, Type 2; Diphosphonates; Estrogen Antagonists; Female; Fractures, Bone; Humans; Hyperaldosteronism; Hyperglycemia; Hypertension; Hypoglycemic Agents; Hypolipidemic Agents; Male; Middle Aged; Osteoporosis; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Risk Factors; Selective Estrogen Receptor Modulators

2003
Effects of the selective estrogen receptor modulator LY117018 on growth hormone secretion: In vitro studies.
    Metabolism: clinical and experimental, 2004, Volume: 53, Issue:5

    Topics: Adenoma; Adult; Aged; Animals; Cell Division; Cells, Cultured; Dose-Response Relationship, Drug; Estradiol; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Male; Middle Aged; Pituitary Gland; Pyrrolidines; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Secretory Rate; Selective Estrogen Receptor Modulators; Tamoxifen; Thiophenes

2004
Estrogen stimulation of galanin gene expression and galanin-like immunoreactivity in the rat and its blockade by the estrogen antagonist keoxifene (LY156758).
    Regulatory peptides, 1993, Jun-11, Volume: 45, Issue:3

    Topics: Adenoma; Animals; Chromatography, High Pressure Liquid; Estradiol; Estrogen Antagonists; Female; Galanin; Gene Expression Regulation; Gonadotropins, Equine; Hypothalamus; Neuropeptides; Peptide Biosynthesis; Peptides; Piperidines; Pituitary Gland, Anterior; Radioimmunoassay; Raloxifene Hydrochloride; Rats; Rats, Inbred F344; Rats, Inbred WF; Rats, Sprague-Dawley; RNA, Messenger

1993